ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

New CREG Announcements Made By NCI

October 3, 1975

Neural Stem Cells Track, Treat, Brain Tumors In Mice

November 29, 2002

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures

May 17, 2013